News

Podcast

Innovation Series: A stem cell patch for treating advanced dry AMD

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, about the progress made by a team of USC researchers on a novel stem cell patch for treating advanced dry age-related macular degeneration.

A stem cell patch for treating advanced dry AMD

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the advancements for a novel stem cell patch developed by a team of researchers at USC for the treatment of advanced dry age-related macular degeneration.

Dr. Humayun talks about the inspiration behind the patch, how his expertise in both ophthalmology and biomedical engineering has been crucial, and insights gained from a Phase 1/2a study. Dr. Humayun also outlines the upcoming steps for a multisite Phase 2b clinical trial and envisions the potential future role of the stem cell patch in the treatment of geographic atrophy.

Mandeep S. Singh, MD, PhD

  • Associate professor of ophthalmology and genetic medicine at the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland
  • Recipient of the 2023 Andreas C. Dracopoulous Professorship in Ophthalmology
  • Co-Director of the Genetic Eye Diseases (GEDi) Center and principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM)

Mark S. Humayun, MD, PhD

  • University Professor of Ophthalmology, Keck School of Medicine of USC in Los Angeles, California
  • Cornelius J. Pings Chair in Biomedical Sciences
  • Director, USC Ginsberg Institute for Biomedical Therapeutics
  • Co-Director USC Roski Eye Institute
  • Received the National Medal of Technology and Innovation from President Barack Obama in 2016 for his innovative work and development of the Argus II.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
© 2025 MJH Life Sciences

All rights reserved.